In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.05 below Cv Sciences Inc average.

Within Major Pharmaceutical Preparations industry 503 other companies have achieved higher Quick Ratio than Cv Sciences Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 4250 to 4605.

Explain Quick Ratio?
How much Cash & cash equivalents CVSI�s has?
What are CVSI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CVSI Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-9.57 %	-25.68 %	-19.45 %	-26.11 %	-9.37 %
Y / Y Cash & cash equivalent Change	-69.98 %	-61.95 %	-38.77 %	-61.08 %	85.74 %
Quick Ratio MRQ	0.05	0.08	0.06	0.08	0.16
CVSI's Total Ranking	# 4605	# 4250	# 4278	# 5117	# 4269
Seq. Current Liabilities Change	30.11 %	-22.8 %	8.42 %	-16.96 %	6.92 %
Seq. Cash & cash equivalent Change	-13.92 %	11.15 %	-27.03 %	-57 %	9.11 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 504
Healthcare Sector	# 987
Overall Market	# 4743

Quick Ratio Statistics
High	Average	Low
31.01	1.66	0
(Mar 31 2014)		(Jun 30 2012)

Financial Statements
Cv Sciences Inc 's Current Liabilities	$ 5 Millions	Visit CVSI's Balance sheet
Cv Sciences Inc 's Cash & cash equivalent	$ 0 Millions	Visit CVSI's Balance sheet
Source of CVSI's Sales		Visit CVSI's Sales by Geography

Cumulative Cv Sciences Inc 's Quick Ratio

CVSI's Quick Ratio for the trailling 12 Months

CVSI Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-20.27 %	-19.96 %	-17.34 %	-12.46 %	-5.53 %
Y / Y Cash & cash equivalent TTM Growth	-60.59 %	-31.89 %	-8.36 %	-26.26 %	-23.62 %
Quick Ratio TTM	0.07	0.1	0.12	0.12	0.14
Total Ranking TTM	# 2850	# 2814	# 2938	# 3573	# 2906
Seq. Current Liabilities TTM Growth	-2.79 %	-6.55 %	-5.6 %	-7.03 %	-2.42 %
Seq. Cash & cash equivalent TTM Growth	-33.44 %	-21.34 %	-6.95 %	-19.1 %	15.03 %

Quick ratio ranking by company, industry and sector >> Back to CVSI Financial Strength Comparisons >> Go to Compare CVSI Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CVSI's Current Liabilities to $4.94 millions, cumulative Quick Ratio to 0.07 below the CVSI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 459 other companies have achieved higher Quick Ratio than Cv Sciences Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 4128.

Explain Quick Ratio?
How much Cash & cash equivalents CVSI�s has?
What are CVSI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 460
Healthcare Sector	# 935
Within the Market	# 4605

trailing twelve months Quick Ratio Statistics
High	Average	Low
11.82	1.1	0
(Sep 30 2014)		(Dec 31 2012)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Alaunos Therapeutics Inc	0.14	$ 0.124 Millions	$ 0.864 Millions
Cumberland Pharmaceuticals Inc	0.11	$ 3.862 Millions	$ 35.193 Millions
Igc Pharma Inc	0.11	$ 0.354 Millions	$ 3.287 Millions
Tuhura Biosciences Inc	0.11	$ 0.996 Millions	$ 9.255 Millions
Gridai Technologies Corp	0.10	$ 1.380 Millions	$ 14.146 Millions
Bioxcel Therapeutics Inc	0.09	$ 12.841 Millions	$ 137.149 Millions
Galectin Therapeutics Inc	0.09	$ 13.275 Millions	$ 151.619 Millions
Lftd Partners Inc	0.08	$ 0.304 Millions	$ 3.648 Millions
Processa Pharmaceuticals Inc	0.08	$ 0.196 Millions	$ 2.387 Millions
Cv Sciences Inc	0.05	$ 0.266 Millions	$ 4.943 Millions
Citius Pharmaceuticals Inc	0.05	$ 17.008 Millions	$ 333.952 Millions
Sunshine Biopharma Inc	0.05	$ 0.281 Millions	$ 5.619 Millions
Hcw Biologics Inc	0.04	$ 0.741 Millions	$ 18.648 Millions
China Pharma Holdings Inc	0.04	$ 0.305 Millions	$ 7.682 Millions
Bioxytran Inc	0.03	$ 0.177 Millions	$ 5.275 Millions
Cdt Equity Inc	0.03	$ 0.700 Millions	$ 23.351 Millions
Shuttle Pharmaceuticals Holdings Inc	0.03	$ 0.102 Millions	$ 3.481 Millions
Northwest Biotherapeutics Inc	0.01	$ 0.595 Millions	$ 42.982 Millions

Date modified: 2026-09-12T06:18:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.